Effect of Gender on Outcomes After Cardiac Resynchronization Therapy in Patients With a Narrow QRS Complex: A Subgroup Analysis of the EchoCRT Trial
暂无分享,去创建一个
Jeroen J. Bax | Jagmeet P. Singh | K. Dickstein | J. Brugada | H. Krum | F. Ruschitzka | I. Ford | J. Borer | W. Abraham | J. Gorcsan | N. Varma | P. Søgaard | D. Gras | J. Steffel | M. Robertson | J. Holzmeister
[1] Anne L. Taylor. Heart Failure in Women , 2015, Current Heart Failure Reports.
[2] David G. Strauss,et al. Cardiac resynchronization therapy in women: US Food and Drug Administration meta-analysis of patient-level data. , 2014, JAMA internal medicine.
[3] F. Ruschitzka,et al. Superresponse to Cardiac Resynchronization Therapy , 2014, Circulation.
[4] P. Tchou,et al. Probability and magnitude of response to cardiac resynchronization therapy according to QRS duration and gender in nonischemic cardiomyopathy and LBBB. , 2014, Heart rhythm.
[5] Goldberger Jj,et al. Cardiac-resynchronization therapy in heart failure with a narrow QRS complex. , 2014 .
[6] L. Fauchier,et al. Cardiac-resynchronization therapy in heart failure with a narrow QRS complex. , 2014, The New England journal of medicine.
[7] J. Nielsen,et al. ESC Guidelines on cardiac pacing and cardiac resynchronization therapy , 2014 .
[8] Lluís Mont,et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). , 2013, European heart journal.
[9] S. Solomon,et al. The influence of left ventricular ejection fraction on the effectiveness of cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy). , 2013, Journal of the American College of Cardiology.
[10] Arthur J Moss,et al. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study. , 2012, Journal of the American College of Cardiology.
[11] L. Lund,et al. Women have better long-term prognosis than men after cardiac resynchronization therapy. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[12] S. Solomon,et al. Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial. , 2011, Journal of the American College of Cardiology.
[13] John L Sapp,et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. , 2010, The New England journal of medicine.
[14] Wojciech Zareba,et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. , 2009, The New England journal of medicine.
[15] K. Dickstein,et al. The European cardiac resynchronization therapy survey. , 2009, European heart journal.
[16] P. Heidenreich,et al. Gender Differences in Procedure-Related Adverse Events in Patients Receiving Implantable Cardioverter-Defibrillator Therapy , 2009, Circulation.
[17] C. Klersy,et al. Remission of left ventricular systolic dysfunction and of heart failure symptoms after cardiac resynchronization therapy: temporal pattern and clinical predictors. , 2008, American heart journal.
[18] Nick Freemantle,et al. Prevalence of ECG abnormalities in an international survey of patients with suspected or confirmed heart failure at death or discharge , 2007, European journal of heart failure.
[19] D. Kass,et al. Predictors of Sudden Cardiac Death and Appropriate Shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial , 2006, Circulation.
[20] Lluís Mont,et al. Predictors of lack of response to resynchronization therapy. , 2005, The American journal of cardiology.
[21] J. Daubert,et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.
[22] J. Conti,et al. Ventricular Reverse Remodeling and 6-Month Outcomes in Patients Receiving Cardiac Resynchronization Therapy: Analysis of the MIRACLE Study , 2005, Journal of Interventional Cardiac Electrophysiology.
[23] D. DeMets,et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. , 2004, The New England journal of medicine.
[24] A. Hall,et al. Cell migration: Rho GTPases lead the way. , 2004, Developmental biology.
[25] David O. Martin,et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. , 2002, JAMA.
[26] D. Delurgio,et al. Cardiac resynchronization in chronic heart failure. , 2002, The New England journal of medicine.
[27] R. Passman,et al. Effects of Sex and Age on Electrocardiographic and Cardiac Electrophysiological Properties in Adults , 2001, Pacing and clinical electrophysiology : PACE.
[28] P Kligfield,et al. Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings. , 1987, Circulation.